Skip to Main Content

Paper Details

NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.
Mol Cancer Ther
13
2014
(GBM) xenografts, Akt, EGFR, EGFRvIII, ERBB, ERBB family member, GBM, GBM xenografts, NT113, erlotinib, glioblastoma, glioblastoma xenografts, intracranial, intracranial glioblastoma, intracranial tumor, lapatinib, mice, patients, tumor, wild-type EGFR
Author NameAffiliation
Shi-Yuan ChengFeinberg School of Medicine, Northwestern University
Jann N SarkariaMayo Clinic College of Medicine
Nicholas ButowskiUniversity of California San Francisco
Nicholas ButowskiUniversity of California San Francisco
Theodore NicolaidesUniversity of California San Francisco
Charles D JamesFeinberg School of Medicine, Northwestern University, Illinois. Northwestern Medicine Developmental Therapeutics Institute
  • 1 - 6

Datasets

Release 1.2